Tenaya Therapeutics (TNYA) reported encouraging early data from the first cohort of patients in the MyPEAK-1 clinical trial of TN-201 gene therapy. TN-201 is being developed for the potential ...
SOUTH SAN FRANCISCO - Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a biotechnology firm focusing on heart disease treatments with a market capitalization of $228 million, today shared promising initial ...
SOUTH SAN FRANCISCO - Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a biotechnology firm focusing on heart disease treatments with a market capitalization of $228 million, today shared promising ...
the best way to make the most of this 748,000-acre outdoor wonderland is to pick lodging that lets you maximize your time spent in the park. Tenaya at Yosemite was that place for me. Set in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback